D. Migliorini's Profile

Role	Title	Level	Year	L/R
🐜	Actively personalized vaccination trial for newly diagnosed glioblastoma 64 auth. N. Hilf, Sabrina Kuttruff-Coqui, K. Frenzel, V. Bukur, S. Stevanović, C. Gouttefangeas, M. Plattén, G. Tabatabai, V. Dutoit, S. H. Burg, P. thor Straten, F. Martínez-Ricarte, B. Ponsati, H. Okada, U. Lassen, ... A. Admon, C. Ottensmeier, Alexander Ulges, S. Kreiter, A. Deimling, M. Skardelly, D. Migliorini, J. Kroep, M. Idorn, J. Rodón, Jordi Piró, H. Poulsen, Bracha Shraibman, Katy J. McCann, R. Mendrzyk, M. Löwer, Monika Stieglbauer, C. Britten, D. Capper, M. Welters, J. Sahuquillo, Katharina Kiesel, E. Derhovanessian, E. Rusch, L. Bunse, Colette Song, S. Heesch, C. Wagner, Alexandra Kemmer-Brück, Jorg Ludwig, J. Castle, O. Schoor, A. Tadmor, E. Green, J. Fritsche, M. Meyer, N. Pawlowski, Sonja Dorner, F. Hoffgaard, B. Rössler, D. Maurer, T. Weinschenk, C. Reinhardt, C. Huber, H. Rammensee, H. Singh-Jasuja, U. Şahin, P. Dietrich, W. Wick	9	2018	9 🐜
🐢	Clinical relevance of tumour-associated macrophages M. Pittet, O. Michielin, D. Migliorini	8	2022	8 🐢
🐜	Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies 21 auth. Kevin R. Parker, D. Migliorini, Eric Perkey, K. Yost, A. Bhaduri, P. Bagga, M. Haris, N. Wilson, Fang Liu, K. Gabunia, ... J. Scholler, T. Montine, V. Bhoj, R. Reddy, S. Mohan, I. Maillard, A. Kriegstein, C. June, Howard Y. Chang, A. Posey, Ansuman T. Satpathy	8	2020	8 🐜
🐜	Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas 23 auth. Yibo Yin, A. Boesteanu, Zev A. Binder, Chong Xu, R. Reid, Jesse L. Rodriguez, D. R. Cook, R. Thokala, K. Blouch, Bevin McGettigan-Croce, ... Logan Y Zhang, Christoph Konradt, Alexandria P. Cogdill, M. K. Panjwani, Shuguang Jiang, D. Migliorini, N. Dahmane, A. Posey, C. June, N. Mason, Zhiguo Lin, D. O’Rourke, L. Johnson	7	2018	7 🐜
🦁	CAR T-Cell Therapies in Glioblastoma: A First Look D. Migliorini, P. Dietrich, R. Stupp, G. Linette, A. Posey, C. June	6	2017	6 🦁
🦁	Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients. 21 auth. D. Migliorini, V. Dutoit, M. Allard, Nicole Grandjean Hallez, E. Marinari, V. Widmer, Géraldine Philippin, F. Corlazzoli, R. Gustave, M. Kreutzfeldt, ... N. Blazek, J. Wasem, A. Hottinger, Avinash Koka, S. Momjian, A. Lobrinus, D. Merkler, M. Vargas, P. Walker, A. Patrikidou, P. Dietrich	6	2019	6 🦁
🐜	The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function 19 auth. M. Wenes, A. Jaccard, T. Wyss, N. Maldonado-Pérez, S. Teoh, A. Lepez, Fabrice Renaud, F. Franco, P. Waridel, Céline Yacoub Maroun, ... B. Tschumi, Nina Dumauthioz, Lianjun Zhang, A. Donda, Francisco Martín, D. Migliorini, Sophia Y. Lunt, Ping-Chih Ho, P. Romero	6	2022	6 🐜
🐢	Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma Darel Martínez Bedoya, V. Dutoit, D. Migliorini	6	2021	6 🐢
🐬	Glycan-directed CAR-T cells Catharina Steentoft, D. Migliorini, Tiffany R. King, U. Mandel, C. June, A. Posey	6	2018	6 🐬
🦁	First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies 9 auth. D. Migliorini, N. Mach, Diego Aguiar, R. Vernet, B. Landis, M. Becker, ... T. McKee, V. Dutoit, P. Dietrich	5	2017	5 🦁
🐬	Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells M. Irving, Evripidis Lanitis, D. Migliorini, Z. Ivics, S. Guedan	5	2021	5 🐬